RC202

N/A

Report date: 2025/09/22 13:38:49

Base Information

Drug NameRC202
Drug Alias NameRC202RC-202
ClassificationCell and gene therapy > Gene therapy > Gene editing > RNA editing
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRecoRNA(Guangzhou) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRecoRNA(Guangzhou) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A